文献速递贫血与红细胞疾病造血干细胞移植与细胞治疗

逆向嵌合体自然基因治疗改善范可尼贫血患者血液学表现

Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients.
PubMed 文献 · Am J Hematol · 2021-05-25

该研究评估西班牙转诊中心30年来随访的范可尼贫血(FA)嵌合体患者队列,发现逆向嵌合体患者成年比例更高、血液学发病年龄更晚、骨髓衰竭(BMF)进展更轻,造血干细胞移植(HSCT)需求更低;多系嵌合患者血液学更稳定,无白血病或骨髓增生异常综合征发生。

要点

  • 逆向嵌合体是FA的良好预后因素,与更有利的长期临床结局相关
  • 嵌合患者血液学发病更晚、BMF进展更轻,HSCT需求更低
  • 多系嵌合患者血液学更稳定,未发生白血病或MDS

核心结论

  • 逆向嵌合体是范可尼贫血的良好预后因素,与更有利的长期临床结局相关。

研究设计与样本

  • 回顾性队列研究,纳入西班牙转诊中心30年随访的FA嵌合体患者,定义为DEB染色体断裂试验中多数T细胞无染色体畸变。

主要发现

  • 与非嵌合FA患者相比,嵌合队列中成年患者比例更高,血液学发病年龄更晚,BMF进展更轻。
  • 嵌合患者HSCT需求更低。
  • 多系嵌合患者年龄更大、异常细胞百分比更低、血液学更稳定,且无一例发生白血病或骨髓增生异常综合征。

临床怎么用

  • FA患者应评估逆向嵌合体状态,嵌合患者尤其多系嵌合者血液学病程可能更惰性,HSCT需求可能更低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fanconi anemia (FA) is characterized by chromosome fragility, bone marrow failure (BMF) and predisposition to cancer. As reverse genetic mosaicism has been described as "natural gene therapy" in patients with FA, we sought to evaluate the clinical course of a cohort of FA mosaic patients followed at referral centers in Spain over a 30-year period. This cohort includes patients with a majority of T cells without chromosomal aberrations in the DEB-chromosomal breakage test. Relative to non-mosaic FA patients, we observed a higher proportion of adult patients in the cohort of mosaics, with a later age of hematologic onset and a milder evolution of (BMF). Consequently, the requirement for hematopoietic stem cell transplant (HSCT) was also lower. Additional studies allowed us to identify a sub-cohort of mosaic FA patients in whom the reversion was present in bone marrow (BM) progenitor cells leading to multilineage mosaicism. These multilineage mosaic patients are older, have a lower percentage of aberrant cells, have more stable hematology and none of them developed leukemia or myelodysplastic syndrome when compared to non-mosaics. In conclusion, our data indicate that reverse mosaicism is a good prognostic factor in FA and is associated with more favorable long-term clinical outcomes.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Ramírez MJ, Pujol R, Trujillo-Quintero JP, et al. Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients. Am J Hematol. 2021. PMID: 33984160. doi:10.1002/ajh.26234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。